Cell & gene therapy (CGT) develops engineered cells (CAR-T, TCR-T, NK, iPSC-derived) and gene-delivery vectors (AAV, lentivirus, LNP-mRNA) to treat cancer, rare diseases and genetic disorders. It combines vector design, manufacturing/CMC, potency assays, vector copy number analytics and ATMP-specific regulation (FDA OTAT, EMA CAT).
A baseline path through this sector with milestones, prerequisites, and concrete projects. Click Personalize this roadmap above to have the AI tailor pace, depth, and resources to your background and goals.
Build the conceptual and quantitative base needed to read papers and follow tutorials in the sector.
Walk through a published tutorial in Benchling + Python/R analytics + AAV/LNP design tools and reproduce its results on the provided sample data.
Deliverable: GitHub repo with a Jupyter/Quarto notebook, environment.yml, and README
Learn the standard analytical stack of the sector and the canonical public datasets used by professionals.
Pick one study from ClinicalTrials.gov CGT cohort + Addgene plasmid repository, reproduce the headline result, and write a short technical note on what you found.
Deliverable: GitHub repo + 3-page PDF write-up
Move from tutorials to original analyses on real questions. Start showing your work publicly.
Pick a clinical-stage CAR-T or AAV program, reconstruct its design rationale, CMC challenges and clinical results from public data, and propose a next-generation improvement.
Deliverable: 8–10 page strategy brief + reference table
Package your work, target real roles, and prepare to interview in the sector.
Curate 2–3 of your strongest sector projects into a portfolio site with clear case-study writeups, plus a 1-page CV tailored to the target role.
Deliverable: Live portfolio URL + PDF CV + cover letter template
Verified, canonical resources from the official providers in this sector. The AI roadmap builder draws from this same library when it personalizes your roadmap.
Designs and characterizes CAR-T / AAV / LNP products and supports IND-enabling studies.
Develops potency, identity and safety assays and supports regulatory submissions for ATMPs.
Answer a short profile and the AI builder will tailor every phase — pace, hours, tools, and resources — to your background and goals in this sector.
Build my personalized roadmap